These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8833765

  • 1. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
    Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M.
    Brain Res; 1996 Feb 19; 709(2):285-95. PubMed ID: 8833765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M, Maruyama W, Dostert P, Hashizume Y.
    J Neural Transm Suppl; 1997 Feb 19; 50():89-105. PubMed ID: 9120428
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
    Maruyama W, Dostert P, Matsubara K, Naoi M.
    Free Radic Biol Med; 1995 Jul 19; 19(1):67-75. PubMed ID: 7635360
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 9. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.
    Lorenc-Koci E, Smiałowska M, Antkiewicz-Michaluk L, Gołembiowska K, Bajkowska M, Wolfarth S.
    Neuroscience; 2000 Oct 28; 95(4):1049-59. PubMed ID: 10682712
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
    Takahashi T, Maruyama W, Deng Y, Dostert P, Nakahara D, Niwa T, Ohta S, Naoi M.
    J Neural Transm (Vienna); 1997 Oct 28; 104(1):59-66. PubMed ID: 9085193
    [Abstract] [Full Text] [Related]

  • 11. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M.
    J Neurochem; 1992 Aug 28; 59(2):395-400. PubMed ID: 1629715
    [Abstract] [Full Text] [Related]

  • 12. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
    Nagatsu T, Yoshida M.
    Neurosci Lett; 1988 Apr 22; 87(1-2):178-82. PubMed ID: 2898112
    [Abstract] [Full Text] [Related]

  • 13. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Abe K, Taguchi K, Wasai T, Ren J, Utsunomiya I, Shinohara T, Miyatake T, Sano T.
    Brain Res Bull; 2001 Sep 01; 56(1):55-60. PubMed ID: 11604249
    [Abstract] [Full Text] [Related]

  • 14. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M, Maruyama W, Nagy GM.
    Neurotoxicology; 2004 Jan 01; 25(1-2):193-204. PubMed ID: 14697894
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: a microdialysis study.
    Nakahara D, Maruyama W, Hashiguti H, Naoi M.
    Brain Res; 1994 May 02; 644(2):226-32. PubMed ID: 8050034
    [Abstract] [Full Text] [Related]

  • 16. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
    Zhu W, Wang D, Zheng J, An Y, Wang Q, Zhang W, Jin L, Gao H, Lin L.
    Clin Chem; 2008 Apr 02; 54(4):705-12. PubMed ID: 18238832
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M, Maruyama W, Akao Y, Zhang J, Parvez H.
    Toxicology; 2000 Nov 16; 153(1-3):123-41. PubMed ID: 11090952
    [Abstract] [Full Text] [Related]

  • 18. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
    Maruyama W, Naoi M.
    Nihon Yakurigaku Zasshi; 2000 Dec 16; 116(6):333-42. PubMed ID: 11188501
    [Abstract] [Full Text] [Related]

  • 19. Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis study.
    Maruyama W, Nakahara D, Dostert P, Hashiguchi H, Ohta S, Hirobe M, Takahashi A, Nagatsu T, Naoi M.
    Neurosci Lett; 1993 Jan 12; 149(2):115-8. PubMed ID: 8474680
    [Abstract] [Full Text] [Related]

  • 20. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W, Naoi M, Kasamatsu T, Hashizume Y, Takahashi T, Kohda K, Dostert P.
    J Neurochem; 1997 Jul 12; 69(1):322-9. PubMed ID: 9202326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.